A detailed history of Dnca Finance transactions in Zoetis Inc. stock. As of the latest transaction made, Dnca Finance holds 19,800 shares of ZTS stock, worth $2.35 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
19,800
Previous 59,800 66.89%
Holding current value
$2.35 Million
Previous $9.33 Billion 68.93%
% of portfolio
0.2%
Previous 0.71%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$141.13 - $159.19 $5.65 Million - $6.37 Million
-40,000 Reduced 66.89%
19,800 $2.9 Billion
Q2 2025

Aug 13, 2025

SELL
$144.41 - $170.3 $1.16 Million - $1.36 Million
-8,000 Reduced 11.8%
59,800 $9.33 Billion
Q1 2025

May 14, 2025

SELL
$156.48 - $175.67 $31,295 - $35,134
-200 Reduced 0.29%
67,800 $11.2 Billion
Q4 2024

Feb 13, 2025

BUY
$162.24 - $194.42 $6.49 Million - $7.78 Million
40,000 Added 142.86%
68,000 $11.1 Billion
Q2 2024

Jul 15, 2024

BUY
$145.54 - $178.83 $4.08 Million - $5.01 Million
28,000 New
28,000 $4.85 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $55.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Dnca Finance Portfolio

Follow Dnca Finance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dnca Finance, based on Form 13F filings with the SEC.

News

Stay updated on Dnca Finance with notifications on news.